Dr Robert Young_AsthmaFoundation.v5.2017
Featured Review: Chronic obstructive pulmonary disease and long-acting inhalers | Cochrane
Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
Therapeutics Initiative | How do you prescribe ICS to COPD patients?
LABA/LAMA FDC or LABA/ICS FDC in patients with COPD | COPD
Stepwise management of COPD: What is next after bronchodilation? - Marc Miravitlles, Kazuto Matsunaga, Michael Dreher, 2023
Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect
Navigating New Treatment Options for COPD | Consultant360
Chronic obstructive pulmonary disorder (COPD) inhaler criteria - Province of British Columbia
Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine
LABA/LAMA fixed-dose combinations in patients with COPD: a systematic | COPD
Comparisons of exacerbations and mortality among LAMA/LABA combinations in stable chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis | Respiratory Research | Full Text
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar
Ellipta Inhalers We have 5 total inhalers that are ... | GrepMed
Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in Therapy
Pipeline | Chiesi Farmaceutici S.p.A.
Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice - ScienceDirect
effect of laBa/laMa versus laMa or laBa/ICs on safety outcomes | Download Table
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine
Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect
A new alphabet for COPD care | European Respiratory Society
BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone
Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box | European Respiratory Society
